Dr. Sumit A. Shah, MD
Medical Oncology (Medical Oncology Physician)
300 Pasteur Dr
Stanford, CA 94305
Who else practices at this address →
Santa Clara County includes mental health (13% of residents) shortage areas. About shortage areas
- Medicare participating
At a glance
- Medical school
- University of California, San Francisco School of Medicine (2013)
- Years since graduation
- 13
- In the NPI registry since
- 2010
- Medicare patients seen, 2024
- 402
Licensed in California since 2012, according to the Medical Board of California. We show license dates only for the states that publish them in bulk; see which states do. For other states, check the state medical board.
The NPI date is when this clinician registered for a National Provider Identifier, the billing number used on health claims. It is not a license, graduation or board-certification date. What an NPI is
Education and training
- 2013Medical school: University of California, San Francisco School of Medicine
- 2010Registered with an NPI (national billing number; not a license date)
Undergraduate school, residency, fellowship, licensing exams and board certification aren’t in public federal data. Board certification can be confirmed with the certifying board (ABMS member boards for MDs, AOA boards for DOs).
Specialties and state licenses
-
Medical Oncology Physician primary
CA license A120808 (first issued 2012; current) -
Hematology & Oncology Physician
CA license A120808 (first issued 2012; current)
As reported to the NPI registry. To confirm a license is current, check the state medical board.
Where they work
Hospitals
- Stanford Health Care Stanford, CA
- Stanford Health Care Tri-Valley Pleasanton, CA
Medical groups
- Stanford Health Care (3,122 clinicians)
Hospitals this clinician lists with Medicare, and groups they bill Medicare through (Care Compare). Affiliation doesn’t mean they see patients at every location.
Medicare patients and services
- Medicare patients, 2024
- 402
- Services billed
- 1,877
- Patients’ average age
- 76
| Service | Times | Patients |
|---|---|---|
| Established patient office or other outpatient visit, 40-54 minutes | 698 | 265 |
| Established patient office or other outpatient visit, 30-39 minutes | 192 | 117 |
| Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | 151 | 40 |
| New patient office or other outpatient visit, 60-74 minutes | 83 | 83 |
| Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | 33 | 30 |
| Hospital discharge day management, more than 30 minutes | 18 | 17 |
| Telephone medical discussion with physician, 21-30 minutes | 14 | 11 |
Medicare fee-for-service only. CMS leaves out services billed for fewer than 11 patients. These figures describe a practice’s Medicare work; they aren’t a measure of quality.
Medicare prescriptions
| Drug | Prescriptions |
|---|---|
| Abiraterone Acetate | 93 |
| Prednisone Other prescribers in Stanford, CA | 91 |
| Xtandi (enzalutamide) | 34 |
| Orgovyx (relugolix) | 28 |
| Myrbetriq (mirabegron) Other prescribers in Stanford, CA | 24 |
| Ondansetron Hcl Other prescribers in Stanford, CA | 19 |
| Inlyta (axitinib) | 16 |
| Prochlorperazine Maleate Other prescribers in Stanford, CA | 16 |
| Nubeqa (darolutamide) | 15 |
| Dexamethasone Other prescribers in Stanford, CA | 12 |
Prescriptions filled under Medicare Part D, including refills. CMS leaves out drugs prescribed fewer than 11 times.
Payments from drug and device companies
In 2025, 4 companies reported 10 payments worth $575 in total to this clinician.
| Dendreon Pharmaceuticals LLC | $269 |
|---|---|
| Pfizer Inc. | $180 |
| AstraZeneca Pharmaceuticals LP | $106 |
| Abc Home Medical Supply, Inc. | $20.39 |
| Food and Beverage | $575 |
|---|
From CMS Open Payments. A payment is not evidence of wrongdoing; many are for consulting, teaching or meals. Clinicians can review and dispute their records with CMS.
Industry-funded research
Named as a principal investigator on 2 industry-funded studies in 2025, from 2 companies. The companies reported $65,719 in research payments for these studies, mostly to the institutions running them.
- Morpheus UC
Roche Products Limited - IMCODE004
Genentech, Inc.
From CMS Open Payments research payments, where companies name up to five principal investigators per payment. Research payments usually go to hospitals, universities and research sites, not to the investigator personally. A payment is not evidence of wrongdoing.